Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Neuroscience|November 19, 2019
Dietary Supplementation With the Ketogenic Diet Metabolite Beta-Hydroxybutyrate Ameliorates Post-TBI Aggression in Young-Adult Male DrosophilaDerek C Lee, Krishna Vali, Shane R Baldwin, et al.
Cancer Medicine|August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trialLaurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
JAMA Oncology|October 29, 2020
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung CancerBairavi Shankar, Jiajia Zhang, Abdul Rafeh Naqash, et al.
Journal of Neurosurgery|June 4, 2021
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapyPavan P Shah, Jennifer L Franke, Ravi Medikonda, et al.
Frontiers in Oncology|August 22, 2022
Sex-specific differences in immunogenomic features of response to immune checkpoint blockadeSusan C Scott, Xiaoshan M Shao, Noushin Niknafs, et al.
Translational Animal Science|January 28, 2021
Soybean molasses to replace corn for feedlot lambs on growth performance, carcass characteristics, and meat qualityMaria Carolina G Arruda, Marco Tulio C Almeida, João Pedro A Bertoco, et al.
Current Oncology (Toronto, Ont.)|June 23, 2022
An Oncology Urgent Care Clinic for the Management of Immune-Related Adverse Events: A Descriptive AnalysisKai-Li Liang, Sean Tackett, Samantha Myers, et al.
Lung Cancer (Amsterdam, Netherlands)|February 21, 2021
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapyCole Friedes, Turja Chakrabarti, Sarah Olson, et al.
ESMO Open|December 10, 2023
Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasisK Liang, J L Feliciano, K A Marrone, et al.
The Oncologist|August 16, 2022
Clinical Features, Survival, and Burden of Toxicities in Survivors More Than One Year After Lung Cancer ImmunotherapyMelinda L Hsu, Joseph C Murray, Kevin J Psoter, et al.
Pageof 6